Skip to content

13F-HR filed by BRAIDWELL LP

BRAIDWELL LP filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 86 holding rows worth $3,164,360,709.

Accession
0001420506-23-002213
Filed
2023-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2023

A holdings report, 86 entries on the cover page, a total value of $3,164,360,709 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,164,360,709 with VALUE read as dollars as filed, 13F file number 028-23075. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
GUARDANT HEALTH INC40131MAB5NOTE 11/1268,252,000$185,764,510dollars as filedprincipal
NOVOCURE LTD67011XAB9NOTE 11/0135,834,000$118,012,579dollars as filedprincipal
Ascendis Pharma A/S04351PAD3Convertible bond124,000,000$113,770,000dollars as filedprincipal
EXACT SCIENCES CORP30063PAC9NOTE 0.375% 3/0131,000,000$113,721,100dollars as filedprincipal
NANOSTRING TECHNOLOGIES INC63009RAD1BOND145,520,000$112,369,466dollars as filedprincipal
BRIDGEBIO PHARMA INC10806XAB8NOTE 2.500% 3/1114,338,000$109,764,480dollars as filedprincipal
NEUROCRINE BIOSCIENCES INC64125C109COM968,024$108,902,700dollars as filed
NEVRO CORP64157FAC7NOTE 2.750% 4/0109,251,000$102,018,584dollars as filedprincipal
VAXCYTE INC COM92243G108Stock1,619,553$82,564,812dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock2,103,396$71,852,007dollars as filed
Boston Scientific Corporation101137107COM1,164,850$61,504,080dollars as filed
LEGEND BIOTECH CORP52490G102SPONSORED ADS879,564$59,080,314dollars as filed
NUVASIVE INC670704AJ4NOTE 0.375% 3/161,340,000$56,647,490dollars as filedprincipal
INSULET CORP45784PAK7NOTE 0.375% 9/054,500,000$53,573,500dollars as filedprincipal
IRHYTHM HOLDINGS INC COM450056106Stock568,157$53,554,479dollars as filed
GLAUKOS CORP COM377322102Stock695,792$52,358,348dollars as filed
IONIS PHARMACEUTICALS INC462222AD2NOTE 4/052,740,000$51,764,310dollars as filedprincipal
Bridgebio Pharma Inc Note 2.250 percent 2/010806XAD4Convertible67,294,000$50,470,500dollars as filedprincipal
SAREPTA THERAPEUTICS INC803607AD2NOTE 1.250% 9/144,166,000$49,549,835dollars as filedprincipal
TRAVERE THERAPEUTICS INC761299AB2NOTE 2.500% 9/156,031,000$48,220,279dollars as filedprincipal
IMMUNOCORE HLDGS PLC ADS45258D105ADR906,973$47,071,899dollars as filed
Day One Biopharmaceuticals Inc23954D109Common Stock3,715,573$45,590,081dollars as filed
NEOGENOMICS INC64049MAB6NOTE 0.250% 1/162,601,000$45,191,662dollars as filedprincipal
NATERA INC COM632307104Stock1,012,145$44,787,416dollars as filed
KEROS THERAPEUTICS INC COM492327101Stock1,357,309$43,271,011dollars as filed
ALPHATEC HLDGS INC02081GAB8NOTE 0.750% 8/044,750,000$43,099,844dollars as filedprincipal
DECIPHERA PHARMACEUTICALS IN24344T101COM3,336,221$42,436,731dollars as filed
PARAGON 28 INC69913P105COM3,361,824$42,190,891dollars as filed
KARYOPHARM THERAPEUTICS INC48576UAA4BOND65,976,000$40,943,996dollars as filedprincipal
MARAVAI LIFESCIENCES HLDGS A56600D107COMMON STOCK3,974,857$39,748,570dollars as filed
INSMED INC457669AA7NOTE 1.750% 1/139,963,000$39,723,222dollars as filedprincipal
Thermo Fisher Scientific Inc.883556102COM75,749$38,341,871dollars as filed
ALIGN TECHNOLOGY INC COM016255101Stock125,213$38,230,033dollars as filed
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock5,362,980$37,969,898dollars as filed
IRONWOOD PHARMACEUTICALS INC46333XAF5BOND37,509,000$37,250,188dollars as filedprincipal
DEXCOM INC252131AK3NOTE 0.250%11/137,500,000$35,531,250dollars as filedprincipal
NEVRO CORP64157F103COM1,776,368$34,141,793dollars as filed
ORTHOPEDIATRICS CORP68752L100COMMON STOCK1,057,770$33,848,640dollars as filed
Intuitive Surgical,Inc.46120E602COM114,920$33,589,967dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM1,735,182$26,617,692dollars as filed
ALECTOR INC014442107COMMON STOCK4,074,120$26,400,298dollars as filed
NEOGENOMICS INC64049MAA8Convertible Debt28,000,000$26,250,000dollars as filedprincipal
OUTSET MEDICAL INC690145107COM2,400,427$26,116,646dollars as filed
HARROW INC415858109COM1,808,684$25,990,789dollars as filed
BICYCLE THERAPEUTICS PLC-ADR088786108SPONSORED ADS1,289,872$25,913,528dollars as filed
89BIO INC282559103COM1,590,387$24,555,575dollars as filed
PENUMBRA INC COM70975L107Stock95,315$23,057,652dollars as filed
GUARDANT HEALTH INC COM40131M109Stock689,000$20,421,960dollars as filed
LANTHEUS HLDGS INC516544103COM288,300$20,031,084dollars as filed
CUTERA INC232109AD0NOTE 2.250% 6/033,900,000$19,980,660dollars as filedprincipal
INSPIRE MED SYS INC COM457730109Stock100,300$19,903,532dollars as filed
AXONICS INC05465P101COM354,527$19,896,055dollars as filed
HILLEVAX INC43157M102COM1,449,246$19,492,359dollars as filed
MINERALYS THERAPEUTICS INC603170101COM2,023,900$19,247,289dollars as filed
Danaher Corporation235851102COM77,200$19,153,320dollars as filed
ANAPTYSBIO INC032724106COM1,049,823$18,854,821dollars as filed
REPLIGEN CORP COM759916109Stock118,400$18,826,784dollars as filed
PROTAGONIST THERAPEUTICS74366E102COM1,109,150$18,500,622dollars as filed
TRAVERE THERAPEUTICS INC89422GAA5CNV28,350,000$18,393,480dollars as filedprincipal
RAPT THERAPEUTICS INC75382E109COM1,082,512$17,991,349dollars as filed
CULLINAN THERAPEUTICS INC230031106COM1,908,865$17,275,228dollars as filed
INCYTE CORP COM45337C102Stock294,900$17,036,373dollars as filed
TRANSMEDICS GROUP INC89377M109COM307,200$16,819,200dollars as filed
DBV TECHNOLOGIES S A23306J101ADR12,107,785$16,466,588dollars as filed
DYNE THERAPEUTICS INC COM26818M108Stock1,821,972$16,324,869dollars as filed
IRONWOOD PHARMACEUTICALS INC46333XAH1NOTE 1.500% 6/115,500,000$15,141,950dollars as filedprincipal
INVITAE CORP46185LAB9NOTE 2.000% 9/016,781,000$14,850,082dollars as filedprincipal
TERNS PHARMACEUTICALS INC COM880881107Stock2,840,052$14,285,462dollars as filed
INTEGRA LIFESCIENCES HLDGS C457985AM1NOTE 0.500% 8/114,500,000$13,296,500dollars as filedprincipal
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK1,348,099$12,982,193dollars as filed
COMPASS THERAPEUTICS INC20454B104COM5,954,273$11,729,918dollars as filed
ENANTA PHARMACEUTICALS INC29251M106COM1,038,310$11,597,923dollars as filed
PROCEPT BIOROBOTICS CORP COM74276L105Stock331,061$10,862,111dollars as filed
THIRD HARMONIC BIO INC88427A107COM1,653,991$10,569,002dollars as filed
APOGEE THERAPEUTICS INC COM03770N101Stock491,113$10,460,707dollars as filed
PULMONX CORP745848101COM988,559$10,211,814dollars as filed
SKINHEALTH SYSTEMS INC88331L108COM CL A1,626,236$9,789,941dollars as filed
Amgen Inc.031162100COM36,200$9,729,112dollars as filed
SEAGEN INC81181C104COM42,497$9,015,739dollars as filed
KRYSTAL BIOTECH INC COM501147102Stock77,497$8,989,652dollars as filed
REPLIMUNE GROUP INC76029N106COMMON STOCK487,520$8,341,467dollars as filed
AGENUS INC00847G705COM NEW6,307,030$7,126,944dollars as filed
RAYZEBIO INC75525N107COM277,778$6,166,672dollars as filed
ALX ONCOLOGY HOLDINGS INC00166B105COMMON STOCK1,249,900$5,999,520dollars as filed
ADAPTIVE BIOTECHNOLOGIES CORP COM00650F109Stock967,690$5,273,911dollars as filed
MERUS N VN5749R100COM1,901,337$0dollars as filedValue filed as zero, left out of ratios.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-23-002213this filing2023-11-14acceptance time not in the bulk data set